Cellular- versus extracellular-based assays. Comparing utility in DNA and RNA molecular marker assessment

Annals of the New York Academy of Sciences

Volumn 906, Issue , 2000, Pages 124-128

  Kopreski, Michael S ^a   Gocke, Christopher D ^b  

^a PFIZER INC   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA MARKER; RNA;

ASSAY; CANCER DIAGNOSIS; CONFERENCE PAPER; DNA DETERMINATION; HUMAN; INTERMETHOD COMPARISON; METASTASIS; RNA ANALYSIS;

EID: 0034057753     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06601.x     Document Type: Conference Paper

References (24)

1. 1. TADA, M., M. OMATA, S. KAWAI et al. 1993. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 53: 2472-2474.
2. 2. MORENO, J.G., C.M. CROCE, R. FISCHER et al. 1992. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 52: 6110-6112.
3. 3. SMITH, B., P. SELBY, J. SOUTHGATE et al. 1991. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229.
4. 4. HOON, D.S.B., Y. WANG, P.S. DALE et al. 1995. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol. 13: 2109-2116.
5. 5. DATTA, Y.H., P.T. ADAMS, W.R. DROBYSKI et al. 1994. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol. 12: 475-482.
6. 6. NEGRIN, R.S. & J. PESANDO. 1994. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J. Clin. Oncol. 12: 1021-1027.
7. 7. GRIBBEN, J., D. NEUBERG, A. FREEDMAN et al. 1993. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81: 3449-3457.
8. 8. GOCKE, C.D., F.A. BENKO, L. STERNAS et al. 1997. Detection of tumor-specific extracellular DNA (the bcl-2/IgH transgene) in serum of untreated follicular lymphoma patients (abstract). Lab. Invest. 76: 126A.
9. 9. KOPRESKI, M.S., F.A. BENKO, D.J. BORYS et al. 1998. Mutated KRAS DNA in plasma as a marker in early colorectal neoplasia (abstract). Proc. Am. Soc. Clin. Oncol. 17: 269a.
10. 10. HARDINGHAM, J.E., D. KOTASEK, R.E. SAGE et al. 1995. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol. Med. 1: 789-794.
11. 11. GLASER, R., K. RASS, S. SEITER et al. 1997. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J. Clin. Oncol. 15: 2818-2825.
12. 12. FARTHMANN, B., J. EBERLE, K. KRASAGAKIS et al. 1998. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J. Invest. Dermatol. 110: 263-267.
13. 13. REINHOLD, U., H.C. LUDTKE-HANDJERY, S. SCHNAUTZ et al. 1997. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J. Invest. Dermatol. 108: 166-169.
14. 14. RHODES, C.H., C. HONSINGER & G.D. SORENSON. 1995. PCR-detection of tumor-derived p53 DNA in cerebrospinal fluid. Am. J. Clin. Pathol. 103: 404-408.
15. 15. REDDI, K.K. & J.F. HOLLAND. 1976. Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Natl. Acad. Sci. U.S.A. 73: 2308-2310.
16. 16. KOMEDA, T., Y. FUKUDA, T. SANDO et al. 1995. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75: 2214-2219.
17. 17. KAMM, R.C. & A.G. SMITH. 1972. Nucleic acid concentrations in normal human plasma. Clin. Chem. 18: 519-522.
18. 18. STROLIN, M., P. ANKER, M. BELJANSKI et al. 1978. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res. 38: 3546-3554.
19. 19. ROSI, A., L. GUIDONI, A.M. LUCIANI et al. 1988. RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells. Cancer Lett. 39: 153-160.
20. 20. BARZ, D., M. GOPPELT, M. SZAMEL et al. 1985. Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasing lymphoma (Eb) and its metastasing variant (Esb). Biochim. Biophys. Acta 814: 77-84.
21. 21. CARR, J.M., A.M. DVORAK & H.F. DVORAK. 1985. Circulating membrane vesicles in leukemic blood. Cancer Res. 45: 5944-5951.
22. 22. MOUNTFORD, C.E., G.L. MAY, L.C. WRIGHT et al. 1987. Proteolipid identified by magnetic resonance spectroscopy in plasma of a patient with borderline ovarian tumour. Lancet 1: 829-834.
23. 23. WIECZOREK, A.J., C. RHYNER & L.H. BLOCK. 1985. Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc. Natl. Acad. Sci. U.S.A. 82: 3455-3459.
24. 24. KOPRESKI, M.S., F.A. BENKO, L.W. KWAK et al. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5: 1961-1965.